# Randomized Evaluation and Verification of Ventricular Enhancement

> **NCT03845127** · NA · WITHDRAWN · sponsor: **BioVentrix**

## Conditions studied

- Ischemic Cardiomyopathy
- Heart Failure

## Interventions

- **DEVICE:** Revivent TC Ventricular Enhancement System
- **DRUG:** GDMT

## Key facts

- **NCT ID:** NCT03845127
- **Lead sponsor:** BioVentrix
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2025-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03845127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03845127, "Randomized Evaluation and Verification of Ventricular Enhancement". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03845127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*